IndraLab
Statements
USP39 affects cell population proliferation
|
2
62
2
USP39 affects apoptotic process
|
42
USP39 affects cell cycle
|
31
USP39 is modified
17
|
2
USP39 affects Neoplasm Invasiveness
|
4
11
USP39 affects Neoplasm Metastasis
|
1
10
USP39 affects cell growth
|
9
1
USP39 affects Circulin-C
|
8
Bisphenol A affects USP39
4
|
USP39 affects cell migration
|
1
2
USP39 affects angiogenesis
|
3
USP39 affects Interferon
|
3
USP39 affects Carcinogenesis
|
2
1
Methyl methanesulfonate affects USP39
2
|
USP39 affects transcription, DNA-templated
|
2
USP39 affects splicing efficiency HMGA2
|
2
USP39 affects phenazine-1-carboxylate
|
2
USP39 affects miR-133a
|
2
USP39 affects invasion potential ovarian cancer cells
|
2
USP39 affects invasion ovarian cancer cells
|
2
|
2
USP39 affects cytokinesis
|
2
USP39 affects carboplatin
|
2
Trimellitic anhydride affects USP39
1
|
Tetrachloromethane affects USP39
1
|
Sodium arsenite affects USP39
1
|
Sodium arsenate affects USP39
1
|
Small interfering RNA affects USP39
|
1
Short hairpin RNA affects USP39
|
1
ShRNA affects USP39
|
1
Potential transcription affects USP39
|
1
Pirinixic acid affects USP39
1
|
Perfluorooctane-1-sulfonic acid affects USP39
1
|
Overexpression c-MYC affects USP39
|
1
Oncogene protein c-MYC affects USP39
|
1
Oncogene protein c-MYC ovarian cancer cells affects USP39
|
1
Nimesulide affects USP39
1
|
Nefazodone affects USP39
1
|
MiR-370-3p affects USP39
|
1
MiR-133a affects USP39
|
1
Methamphetamine affects USP39
1
|
Mercury(0) affects USP39
1
|
Indometacin affects USP39
1
|
Hydroperoxide affects USP39
1
|
Hsa-miR-193b-3p affects USP39
1
|
Glyphosate affects USP39
1
|
Gentamycin affects USP39
1
|
Dexamethasone affects USP39
1
|
Deoxynivalenol affects USP39
1
|
Carbon nanotube affects USP39
1
|
Cadmium atom affects USP39
1
|
Benzo[a]pyrene affects USP39
1
|
All-trans-retinoic acid affects USP39
1
|
Acrylamide affects USP39
1
|
YP_009227196 affects USP39
1
|
Vehicle Emissions affects USP39
1
|
Ualcan databases affects USP39
|
1
USP4 affects UBL
|
1
USP4 affects UBL domain
|
1
USP39 affects β-amyrin
|
1
USP39 affects tumorigenic potential
|
1
USP39 affects tumorigenesis ovarian cancer nude mice xenografts
|
1
USP39 affects tumor growth glioma
|
1
USP39 affects translation
|
1
USP39 affects stability p53 protein
|
1
USP39 affects splicing
|
1
USP39 affects splicing exon-exon minigene transcripts
|
1
USP39 affects signal transduction
|
1
USP39 affects proliferation- related genes
|
1
USP39 affects pre-mRNA splicing efficiency
|
1
USP39 affects p53-responsive transcriptional reporter
|
1
USP39 affects p53 pathway
|
1
USP39 affects overall survival mice
|
1
USP39 affects ovarian cancer cells
|
1
USP39 affects non-homologous end-joining repair
|
1
USP39 affects migration
|
1
USP39 affects migration invasion cells
|
1
USP39 affects metastasis lung cancer cells
|
1
USP39 affects metabolic process
|
1
USP39 affects malignancy ovarian cancer cells
|
1
USP39 affects mRNA processing
|
1
USP39 affects invasion glioma cells
|
1
USP39 affects human glioma cells migration
|
1
USP39 affects growth xenograft tumors
|
1
USP39 affects growth subcutaneous tumor colon cancer cells
|
1
USP39 affects glioma25
|
1
USP39 affects exonic reads
|
1
USP39 affects epithelial-mesenchymal transition EMT ovarian cancer cells
|
1
USP39 affects colony
|
1
USP39 affects colony A549 cells
|
1
USP39 affects clonogenicity
|
1
USP39 affects clonogenic capacity
|
1
USP39 affects cisplatin-induced apoptosis HCT116 cells
|
1
USP39 affects chromosome segregation
|
1
USP39 affects cell-cycle-
|
1
USP39 affects cell migration invasion USP39KD cells
|
1
USP39 affects cell migration A549 HCC827 cells
|
1
USP39 affects cell growth aerobic glycolysis oral cancer
|
1
USP39 affects cell death
|
1
USP39 affects apoptosis induced cisplatin
|
1
USP39 affects antitumor cisplatin colon cancer cells dependent p53
|
1
USP39 affects activation p53 pathway
|
1
USP39 affects accumulation p53
|
1
USP39 affects abnormal cell cycle distribution
|
1
USP39 affects YP_009227196
1
|
USP39 affects Wnt/β-catenin
|
1
USP39 affects VEGF-A165b
|
1
USP39 affects UBL
|
1
USP39 affects UBL domain
|
1
USP39 affects TAZ mRNA
|
1
USP39 affects Spliceosomes
|
1
USP39 affects SUMOylation specific protein
|
1
USP39 affects RP23-384C18.4
1
|
USP39 affects PC
|
1
USP39 affects Metastatic Cells Vitro potential contribution USP39 metastatic capacity A549 HCC827 cells performed Matrigel non-coated Transwell migration coated Transwell invasion assays
|
1
USP39 affects K63
|
1
USP39 affects IFN-mediated antiviral responses
|
1
USP39 affects HIV1gp6
1
|
|
1
USP39 affects Delta-actitoxin-Avd1a
|
1
USP39 affects CyclinB1
|
1
USP39 affects Colonic Neoplasms
|
1
USP39 affects Cell Survival
|
1
USP39 affects Carcinoma, Renal Cell
|
1
USP39 affects CDC2 cyclinB1
|
1
USP39 affects ADAM9 mRNA maturation
|
1
USP39 affects ADAM9 cells
|
1
UBL affects USP4
|
1
UBL domain affects USP4
|
1
Surface-Active Agents affects USP39
1
|
RP23-384C18.4 affects USP39
1
|
Plant Extracts affects USP39
1
|
N-methyl-4-phenylpyridinium affects USP39
1
|
LINC00623 affects USP39
|
1
HIV1gp6 affects USP39
1
|
Delta-actitoxin-Avd1a affects USP39
|
1
3-isobutyl-1-methyl-7H-xanthine affects USP39
1
|
1
|
17alpha-ethynylestradiol affects USP39
1
|